DONNA RONDEAU-MARZULLO: Open Payments
NPI 1043409790 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 5 payments from 3 companies in 2025. Trend: 2023 $446 · 2024 $242 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $135 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
Products named: REXULTI, AUSTEDO XR, FANAPT.
Industry payments across RI — which companies pay providers there.
